Focusing on patients with high-cost rare disease states such as hemophilia, hereditary angioedema, and multiple sclerosis, AscellaHealth ensures that these patients receive faster access to the right therapies and full-spectrum support to improve health outcomes while reducing costs associated with avoidable hospitalizations and complications.